APOL1 Gene and Long-Term Kidney Transplant Outcomes
Official title: 1-13 ApoL1 Genotypes in Kidney Donors and Long-Term Outcomes in Kidney Transplant Recipients Clinical Center
Funded at University of Miami School of Medicine · NIH-11137838 · Data updated 2026-11-12
This project looks at how a gene called APOL1 in kidney donors might affect how well transplanted kidneys work over time for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project start | September 25, 2017 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $262,377 |
| NIH project number | 5U01DK116101-08 |
| Project ID | NIH-11137838 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are kidney transplant recipients and living kidney donors who have received or donated a kidney at participating centers in Florida, Puerto Rico, or California.
✕Less likely to help
Patients who have not undergone a kidney transplant or donated a kidney would not directly benefit from participating in this specific observational study.
What this research studies
This project is part of a larger network called APOLLO, which is conducting the biggest observational study to date on kidney transplant recipients and donors. We are studying a specific gene called APOL1 in kidney donors to see if certain changes in this gene might be linked to how long a transplanted kidney lasts. Our center has been a leader in enrolling both kidney transplant recipients and living kidney donors from Florida, Puerto Rico, and California. By collecting DNA from these participants, we hope to better understand the factors that influence long-term kidney transplant success. This information could help doctors make more informed decisions and improve outcomes for patients receiving kidney transplants.
Why it matters
Potential benefit: If successful, this work could help doctors better predict the long-term success of kidney transplants and personalize care for patients based on donor genetics.
How similar studies have gone: This project is part of the largest observational study of its kind, building upon existing knowledge about APOL1 and kidney transplantation.
Where this research is happening
-
University of Miami School of Medicine
Coral Gables, United States Active
Researchers
- Principal investigator: Fornoni, Alessia — University of Miami School of Medicine
- Study coordinator: Fornoni, Alessia
Related research
Other NIH-funded projects on the same topics.
-
Microbial clues to diagnose and predict infections in kidney transplant patients
A patient-focused project will look for microbial biomarkers in stool, blood, and urine to help doctors predict and diagnose infections in people who have had a kidney transplant.
-
Immunological mechanisms behind treatment-resistant kidney transplant rejection
This grant explores why certain kidney transplant rejections don’t respond to standard treatments and what immune cells in the graft are driving that resistance.
-
Complement-Bound Exosomes and Kidney Transplant Immunity
This project studies how kidney transplant injury and rejection happen after surgery and whether blocking certain immune pathways during organ preservation could improve transplant outcomes.
-
Blood vessel signals predicting heart problems after kidney transplant
This project studies blood markers and tissue patterns after kidney transplants to identify which patients are at highest risk of cardiovascular problems.
-
Understanding how BK virus links infection to kidney transplant rejection
This project looks at how BK polyomavirus reactivation affects kidney transplant patients and aims to use pre-transplant T cell information to tailor immunosuppression and monitoring.
-
Characterization of a LILRB3 SNP cluster and its link to kidney transplant outcomes
A study in kidney transplant recipients looks at genetic factors that may be tied to higher risk of graft failure.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.